Portfolio

ProteinSimple

Develops instrumentation systems, software and assay products that drive discoveries in fields ranging from fundamental protein research to biomarker discovery and personalized medicine


A leading innovator in the protein analysis market

The dramatic growth in biopharmaceuticals has been driven in large part by our improved understanding of proteins.  ProteinSimple helps researchers gain a better understanding of proteins and their role in disease by making protein research simpler and more quantitative.  ProteinSimple has built a portfolio of protein analysis tools including systems for traditional protein imaging, systems to probe the structure and purity of protein based therapeutics and systems that provide fresh insight into protein signalling.  ProteinSimple has over 170 employees, over 14,000 systems installed around the world and is headquartered in Santa Clara, California. 

After identifying the attractive growth equity ivnestment backed by a seasoned management team, Essex Woodlands acquired its minority stake in 2010.  Essex Woodlands has led two rounds of funding to support the company's rapid organic growth and acquisitions in the protein analysis segment of the life science tools market. 

Transaction Summary

  • Santa Clara, CA
  • NASDAQ: TECH

  • Contact:
    Ron Eastman
  • www.bio-techne.com
  • Formerly Known As: ProteinSimple
  • Acquired by: Techne Corporation (d/b/a Bio-Techne)
  • Exit date: August 01, 2014
  • Logo

Related News